Table 2.
Trial characteristic | Odds Ratio | 95% C.I. | p-value |
---|---|---|---|
Era 1999 – 2002 2003 – 2005 2006 – 2008 |
Reference 0.84 0.80 |
Reference 0.49, 1.46 0.45, 1.43 |
Reference 0.54 0.45 |
Number of patients enrolled 0 – 52 53 – 123 ≥124 |
Reference 0.82 0.59 |
Reference 0.47, 1.42 0.32, 1.07 |
Reference 0.48 0.08 |
Location of Patient Enrollment Enrollment only in the U.S. Enrollment in the U.S. and Non-U.S. countries Enrollment only in non-U.S. |
Reference 1.08 1.62 |
Reference 0.34, 3.39 0.82, 3.18 |
Reference 0.90 0.17 |
Immunosuppression trial (versus non-immunosuppression) |
2.40 | 1.36, 4.22 | 0.01 |
Higher impact journal (versus lower) | 1.74 | 1.07, 2.84 | 0.03 |
The multivariable logistic model included all trial characteristics listed in the table